Skip to main content

Losartan potassium (Cozaar).

Publication ,  Journal Article
Lindenfeld, J; Borer, J; Armstrong, PW
Published in: Circulation
April 23, 2002

Duke Scholars

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

April 23, 2002

Volume

105

Issue

16

Start / End Page

e9100

Location

United States

Related Subject Headings

  • Randomized Controlled Trials as Topic
  • Losartan
  • Hypertension
  • Humans
  • Diabetic Nephropathies
  • Diabetes Mellitus, Type 2
  • Cardiovascular System & Hematology
  • Antihypertensive Agents
  • Angiotensin Receptor Antagonists
  • 4207 Sports science and exercise
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lindenfeld, J., Borer, J., & Armstrong, P. W. (2002). Losartan potassium (Cozaar). Circulation, 105(16), e9100. https://doi.org/10.1161/01.cir.0000019667.61241.2b
Lindenfeld, JoAnn, Jeffrey Borer, and Paul W. Armstrong. “Losartan potassium (Cozaar).Circulation 105, no. 16 (April 23, 2002): e9100. https://doi.org/10.1161/01.cir.0000019667.61241.2b.
Lindenfeld J, Borer J, Armstrong PW. Losartan potassium (Cozaar). Circulation. 2002 Apr 23;105(16):e9100.
Lindenfeld, JoAnn, et al. “Losartan potassium (Cozaar).Circulation, vol. 105, no. 16, Apr. 2002, p. e9100. Pubmed, doi:10.1161/01.cir.0000019667.61241.2b.
Lindenfeld J, Borer J, Armstrong PW. Losartan potassium (Cozaar). Circulation. 2002 Apr 23;105(16):e9100.

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

April 23, 2002

Volume

105

Issue

16

Start / End Page

e9100

Location

United States

Related Subject Headings

  • Randomized Controlled Trials as Topic
  • Losartan
  • Hypertension
  • Humans
  • Diabetic Nephropathies
  • Diabetes Mellitus, Type 2
  • Cardiovascular System & Hematology
  • Antihypertensive Agents
  • Angiotensin Receptor Antagonists
  • 4207 Sports science and exercise